Phenotype
|
Fish
|
Conditions
|
Figures
|
otic placode shape, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
fourth ventricle opaque, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
extension decreased thickness, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
midbrain hindbrain boundary aplastic, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
otic placode decreased size, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
optic tectum opaque, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
fourth ventricle increased size, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
fin deformed, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
trunk bent, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
post-vent region bent, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
cerebellum aplastic, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
optic tectum increased size, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
forebrain protruding, abnormal
|
AB + MO1-rpl11
|
standard conditions
|
Fig. 3
from Uechi et al., 2006
|
swim bladder absent, abnormal
|
TU + MO1-rpl11
|
standard conditions
|
Fig. 1
from Liu et al., 2014
|
pericardium edematous, abnormal
|
TU + MO1-rpl11
|
standard conditions
|
Fig. 1
from Liu et al., 2014
|
whole organism cdkn1a expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
|
extension decreased thickness, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. S4
from Chakraborty et al., 2009
|
forebrain increased size, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
intermediate cell mass of mesoderm pcna expression decreased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 2,
Fig. 5
from Ear et al., 2015
|
nucleate erythrocyte irregularly shaped, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 2
from Ear et al., 2015
|
whole organism decreased length, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
head pes expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 3
from Chakraborty et al., 2017
|
erythroid lineage cell absent, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1,
Fig. 3,
Fig. 5
from Ear et al., 2015
|
yolk circular, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. S4
from Chakraborty et al., 2009
|
mandibular arch skeleton malformed, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
intermediate cell mass of mesoderm cell population proliferation decreased occurrence, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 2,
Fig. 5
from Ear et al., 2015
|
inner ear morphology, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
Meckel's cartilage malformed, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
caudal fin shortened, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
|
head apoptotic process increased occurrence, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 2
from Berres et al., 2017
|
pericardium edematous, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
head apoptotic process increased occurrence, abnormal
|
WT + MO1-rpl11
|
control
|
Fig. 2
from Berres et al., 2017
|
otolith deformed, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
Meckel's cartilage decreased length, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
extension morphology, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
|
heart edematous, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
head bop1 expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 3
from Chakraborty et al., 2017
|
whole organism mdm2 expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
|
eye decreased size, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1 ,
Fig. S4
from Chakraborty et al., 2009
|
embryonic neurocranium morphogenesis decreased process quality, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
yolk edematous, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
|
apoptotic process increased occurrence, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 4
from Chakraborty et al., 2009
|
whole organism tp53 expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
|
eye pigmentation delayed, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
nucleate erythrocyte increased size, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 2
from Ear et al., 2015
|
midbrain-hindbrain boundary structural organization disrupted, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
extension decreased size, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
head ccng1 expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. S3
from Chakraborty et al., 2017
|
hemopoiesis process quality, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1 ,
Fig. 4
from Zhang et al., 2013
|
head opaque, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
neurocranium malformed, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
head aplastic, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
|
yolk grey, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. S4
from Chakraborty et al., 2009
|
whole organism lft1 expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 6
from Ear et al., 2015
|
head gnl3 expression increased amount, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 3
from Chakraborty et al., 2017
|
gut aplastic, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
embryonic cranial skeleton morphogenesis decreased process quality, exacerbated
|
WT + MO1-rpl11
|
chemical treatment by environment: ethanol
|
Fig. 1
from Berres et al., 2017
|
head decreased size, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Ear et al., 2015
Fig. 1 ,
Fig. S4
from Chakraborty et al., 2009
|
hindbrain malformed, abnormal
|
WT + MO1-rpl11
|
standard conditions
|
Fig. 1
from Chakraborty et al., 2009
|
nucleate erythrocyte decreased amount, abnormal
|
WT + MO1-rpl11 + MO4-tp53
|
standard conditions
|
Fig. 2
from Chakraborty et al., 2017
|
hemopoiesis process quality, abnormal
|
WT + MO1-rpl11 + MO4-tp53
|
standard conditions
|
Fig. 4
from Zhang et al., 2013
|
erythroid lineage cell EGFP expression decreased amount, abnormal
|
cz3325Tg + MO1-rpl11
|
standard conditions
|
Fig. 2
from Ear et al., 2015
|
erythroid lineage cell increased size, abnormal
|
cz3325Tg + MO1-rpl11
|
standard conditions
|
Fig. 2
from Ear et al., 2015
|
yolk edematous, abnormal
|
zf623Tg + MO1-rpl11
|
standard conditions
|
Fig. 3
from Ear et al., 2015
|
extension morphology, abnormal
|
zf623Tg + MO1-rpl11
|
standard conditions
|
Fig. 3
from Ear et al., 2015
|
head aplastic, abnormal
|
zf623Tg + MO1-rpl11
|
standard conditions
|
Fig. 3
from Ear et al., 2015
|
erythroid lineage cell decreased amount, abnormal
|
zf623Tg + MO1-rpl11
|
standard conditions
|
Fig. 3
from Ear et al., 2015
|
erythroid lineage cell absent, abnormal
|
zf623Tg + MO1-rpl11
|
standard conditions
|
Fig. 3
from Ear et al., 2015
|
nucleate erythrocyte decreased amount, abnormal
|
tp53zdf1/zdf1 + MO1-rpl11
|
standard conditions
|
Fig. 2
from Chakraborty et al., 2017
|
apoptotic process increased occurrence, abnormal
|
WT + MO1-rpl11 + MO1-rpl23 + MO1-rpl5a
|
standard conditions
|
Fig. S5
from Chakraborty et al., 2009
|
brain deformed, abnormal
|
WT + MO1-rpl11 + MO1-rpl23 + MO1-rpl5a
|
standard conditions
|
Fig. S5
from Chakraborty et al., 2009
|
brain morphogenesis disrupted, abnormal
|
WT + MO1-rpl11 + MO1-rpl23 + MO1-rpl5a
|
standard conditions
|
Fig. S5
from Chakraborty et al., 2009
|